China-based Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488) has announced a partnership with China Meheco International Co., Ltd, a wholly-owned subsidiary of China Meheco Group Co., Ltd. The collaboration will focus on project cooperation and investment, leveraging the comprehensive advantages of both companies in information, knowledge, talent, products, and channels to promote business development in government procurement.
Global Expansion and Market Integration
The partnership aims to actively promote the overseas registration of related products, fully utilize regional advantages, integrate resources, and expand markets. Aidea Pharma will find and select competitive local channels, incorporate them into the supply system, and conduct sales promotion worldwide.
Complementary Support and Innovation
Aidea Pharma will leverage its brand, services, and products to provide diversified medical and pharmaceutical service support to Meheco and its recommended customers. This includes regular business training on medical and pharmaceutical products, promoting innovation in medical and pharmaceutical products, and providing personalized and differentiated services and product support to drive sustained sales growth for Meheco.
Conversely, Meheco will actively recommend excellent projects and high-quality customers to Aidea, use its platform to promote Aidea’s products, and increase sales volume. Meheco will also collaborate with Aidea to innovate medical and pharmaceutical service products that meet industry development needs, actively maintain Aidea’s market image and reputation, and provide after-sales tracking services and overall supervision for product-related issues.-Fineline Info & Tech
